GENERAL1 Oct 2026
Gland Pharma to invest $21 million in US drugmaker, take 60% stake - CNBC TV18
Gland Pharma is putting $21 million into its US subsidiary. That unit will buy a 60% stake in Novelstar Pharma, a newly formed American company. The move is part of Gland Pharma's push to grow its business in the United States. For Indian pharma suppliers and investors, it signals continued overseas expansion. If you track this sector, watch for future filings on how the deal performs.
Key Statutory Highlights
- Gland Pharma will invest $21 million in its US subsidiary.
- The US subsidiary will acquire a 60% stake in Novelstar Pharma.
- Novelstar Pharma is newly incorporated, and the deal supports Gland Pharma's expansion in America.
Actionable Advice for Taxpayers / Founders:If you hold Gland Pharma shares or supply the company, keep an eye on upcoming company disclosures about this US deal before you take any investment or business decision.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: